Literature DB >> 30333201

A Rare case of recurrent Guillain-Barré syndrome without albuminocytological dissociation.

Anudeep Yelam1, Elanagan Nagarajan2, Raghav Govindarajan1, Pradeep C Bollu1.   

Abstract

Guillain-Barré syndrome (GBS) is an immune-mediated polyneuropathy, often preceded by an illness. It is a self-limiting illness in most of the cases, but recurrence is rare and can be seen in about 1%-6% of patients. GBS is characterised by progressive, symmetrical, proximal and distal weakness. Areflexia and sensory disturbances are also common. Patients with GBS usually have albuminocytological dissociation on cerebrospinal fluid (CSF) analysis. This is a case of a 69-year-old woman with recurrent GBS and normal CSF findings. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  general practice / family medicine; immunology; neurology (drugs and medicines); peripheral nerve disease

Mesh:

Substances:

Year:  2018        PMID: 30333201      PMCID: PMC6202978          DOI: 10.1136/bcr-2018-226572

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  [Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916].

Authors:  G Guillain; J A Barré; A Strohl
Journal:  Ann Med Interne (Paris)       Date:  1999-01

Review 2.  Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Hans-Peter Hartung
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

Review 3.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  R A C Hughes; J C Raphaël; A V Swan; P A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

4.  Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors: 
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

Review 5.  Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Jane Pritchard; Robert D M Hadden
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.

Authors:  Liselotte Ruts; Rinske van Koningsveld; Pieter A van Doorn
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

7.  The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.

Authors:  B C Jacobs; P H Rothbarth; F G van der Meché; P Herbrink; P I Schmitz; M A de Klerk; P A van Doorn
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

8.  Recurrent Guillain-Barré syndrome. Clinical and laboratory features.

Authors:  F Grand'Maison; T E Feasby; A F Hahn; W J Koopman
Journal:  Brain       Date:  1992-08       Impact factor: 13.501

9.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

Authors:  Christiaan Fokke; Bianca van den Berg; Judith Drenthen; Christa Walgaard; Pieter Antoon van Doorn; Bart Casper Jacobs
Journal:  Brain       Date:  2013-10-26       Impact factor: 13.501

10.  An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.

Authors:  Sonali Sihindi Chapa Gunatilake; Rohitha Gamlath; Harith Wimalaratna
Journal:  BMC Neurol       Date:  2016-09-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.